Yayın:
Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy

dc.contributor.authorŞENEL, BEHİYE
dc.contributor.authorBAŞARAN, EBRU
dc.contributor.authorAkyıl, Evrim
dc.contributor.authorBÜYÜKKÖROĞLU, GÜLAY
dc.contributor.authorGülay Büyükköroğlu
dc.contributor.orcid0000-0001-9747-8307
dc.contributor.orcid0000-0003-2104-2069
dc.contributor.orcid0000-0003-1547-0817
dc.contributor.orcid0000-0002-5089-6007
dc.date.accessioned2025-11-13T10:27:39Z
dc.date.issued2024-02-27
dc.identifier.doihttps://doi.org/10.1021/acsomega.3c09098
dc.identifier.endpage11685
dc.identifier.issn2470-1343
dc.identifier.issue10
dc.identifier.openalexW4392193677
dc.identifier.startpage11671
dc.identifier.urihttps://hdl.handle.net/11421/4218
dc.identifier.urihttps://doi.org/10.1021/acsomega.3c09098
dc.identifier.volume9
dc.language.isoen
dc.relation.ispartofACS Omega
dc.rightsopenAccess
dc.subjectDocetaxel
dc.subjectCancer therapy
dc.subjectMedicine
dc.subjectCancer
dc.subjectCancer research
dc.subjectOncology
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleCo-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5076726809
local.authorid.openalexA5076682992
local.authorid.openalexA5094011783
local.authorid.openalexA5039206093

Dosyalar

Koleksiyonlar